Clinical Trials Directory

Trials / Completed

CompletedNCT03666364

Magnetic Nanoparticle Sperm Separation for Teratozoospermia Male and Women Older Than 35 Years

Magnetic Nanoparticle Sperm Separation for ICSI Cycles With Teratozoospermia and Over 35 Years Old Women Age

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
1,400 (actual)
Sponsor
Ibn Sina Hospital · Other Government
Sex
Female
Age
35 Years – 42 Years
Healthy volunteers
Not accepted

Summary

Women over 35 years old are likely to suffer from impaired oocyte repair capacity. Teratozoospermia is a condition reflects morphological affection of sperm. These spermatozoa would add an extra burden on the oocyte after ICSI. Whether selecting mature sperm by magnetic nanoparticle protocol would provide a more competent sperm to a likely affected oocyte would improve ICSI outcomes is the question of this research.

Conditions

Interventions

TypeNameDescription
OTHERSperm preparation for ICSIA new protocol for sperm preparation for ICSI cycles with teratozoospermia in over 35 years old women

Timeline

Start date
2018-09-17
Primary completion
2019-09-20
Completion
2019-10-01
First posted
2018-09-11
Last updated
2019-11-18

Locations

3 sites across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03666364. Inclusion in this directory is not an endorsement.